Blog - Page 4067 of 5386

MondayNov 03, 2008 5:05 am

China Agritech, Inc. (OTC BB: CAGC)

China Agritech, Inc. (OTC BB: CAGC) is a leading developer, manufacturer and distributor of environmentally friendly liquid compound organic fertilizers. As a profitable and rapidly growing U.S. public company operating in the People’s Republic of China, the company provides unique, proprietary fertilizers that are the result of over 12 years of intense research and development in cooperation with leading agricultural experts. For further information, visit the Company's web site at www.chinaagritechinc.com.

MondayNov 03, 2008 5:04 am

Chelsea Therapeutics International, Ltd. (NASDAQ: CHTP)

Chelsea Therapeutics International, Ltd. (NASDAQ: CHTP), a biopharmaceutical development company, is focused on acquiring and developing innovative products designed to treat a variety of human diseases. Currently, the company is developing a portfolio of metabolically inert antifolate compounds engineered to have potent anti-inflammatory and anti-tumor activity to treat a range of immunological disorders. Chelsea Therapeutics purposes to create value by building a world-class team, accelerating the development of its product candidates and expanding its therapeutic pipeline. For further information, visit the Company's web site at www.chelseatherapeutics.com.

MondayNov 03, 2008 5:03 am

Chariot Resources Limited (TSX: CHD CN)

Chariot Resources Limited (TSX: CHD CN) is focused on developing one of the world’s premier advanced stage copper projects. The Company’s 70% owned Marcona Copper Property in Peru is quickly progressing toward feasibility completion and production. The Mina Justa start-up project is poised for near-term production with an offtake agreement already in place, financial contributions from two Korean joint venture partners, and project financing of up to $325 million committed. For further information, visit the Company's web site at www.chariotresources.com www.chariotresources.com.

MondayNov 03, 2008 5:03 am

Qiao Xing Universal Telephone, Inc. (NASDAQ: XING)

Qiao Xing Universal Telephone, Inc. (NASDAQ: XING) is a leading provider of both fixed-line and wireless phones to China's booming telecom market. Experts in the marketplace have called Qiao Xing the most undervalued Chinese ADR and the Chinese Nokia. With a large population in China and the emergence of Cell-Phone technology, this company may be a hidden gem. For further information, visit the company website at: www.qiaoxing.com.

MondayNov 03, 2008 5:02 am

Puda Coal, Inc. (OTC BB: PUDC)

Puda Coal, Inc. (OTC BB: PUDC) specializes in providing premium grade cleaned coking coal to the steel manufacturing industry for the use in making coke in China. The company does this through its operating subsidiary, Shanxi Puda Coal Group Co., Ltd. The company has been growing at a very fast-pace and now provides nearly 50% of China’s coke. For further information, visit the company website at: www.pudacoalinc.com.

MondayNov 03, 2008 5:02 am

pSivida Corp. (NASDAQ: PSDV)

pSivida Corp. (NASDAQ: PSDV) has focused their efforts on developing drug delivery products, with an initial focus on ophthalmology and oncology. The company generates revenues through the marketing of the only two FDA approved sustained release back of the eye treatments for chronic eye disease. Substantial revenues are anticipated shortly from their varied late-stage product portfolio that includes a next generation product designed to treat Diabetic Macular Edema as well as other ophthalmic applications. For further information, visit the Company's web site at www.psivida.com.

MondayNov 03, 2008 5:02 am

Celsion Corporation (NASDAQ: CLN)

Celsion Corporation (NASDAQ: CLN) is committed to developing and commercializing oncology drugs including tumor-targeting treatments. The company has research, license or commercialization agreements with leading institutions such as the National Institutes of Health, Duke University Medical Center, University of Hong Kong, North Shore Hospital-Albert Einstein Medical School. By using technology that delivers high concentrations of anti-cancer agents directly the tumor site, they are able to maximize efficacy while minimizing side-effects common to cancer treatment. For further information, visit the Company's web site at www.celsion.com.

MondayNov 03, 2008 5:01 am

Provectus Pharmaceuticals, Inc. (OTC BB: PVCT)

Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), a development stage company, is focused on safer, more effective, less invasive and more economical oncology and dermatology therapies. Currently, the company is conducting Phase 2 clinical trials of their proprietary drugs designed to treat psoriasis, metastatic melanoma, and atopic dermatitis. Provectus has developed multiple intellectual properties and technologies in the areas of imaging, medical devices and biotechnology. For further information, visit the Company's web site at www.pvct.com.

MondayNov 03, 2008 5:01 am

Cell Therapeutics, Inc. (NASDAQ: CTIC)

Cell Therapeutics, Inc. (NASDAQ: CTIC) is focused on leading the biopharmaceutical industry with their diversified portfolio of proprietary oncology drugs. They manage each and every aspect of the manufacturing process, but outsource their clinical and commercial active pharmaceutical ingredient (API) and finished product (FP) production activities to superior contract manufacturing organizations, both in the US and in Europe. For further information, visit the Company's web site at www.ctiseattle.com.

MondayNov 03, 2008 5:00 am

Protalex, Inc. (OTC BB: PRTX)

Protalex, Inc. (OTC BB: PRTX), a biotechnology company, is focused on developing a new class of drugs designed to treat a variety of autoimmune disorders. PRTX-100, the company’s lead compound, is currently being developed for a rare blood clotting disorder and rheumatoid arthritis. This compound is a highly-purified form of Staphylococcal Protein A (SpA or Protein A) and has been used in FDA-approved extracorporeal immunoadsorption systems for both idiopathic thrombocytopenic purpura and rheumatoid arthritis. For further information, visit the Company's web site at www.protalex.net.

Site Search

Company Search

China Agritech, Inc. (OTC BB: CAGC)

Chelsea Therapeutics International, Ltd. (NASDAQ: CHTP)

Chariot Resources Limited (TSX: CHD CN)

Qiao Xing Universal Telephone, Inc. (NASDAQ: XING)

Puda Coal, Inc. (OTC BB: PUDC)

pSivida Corp. (NASDAQ: PSDV)

Celsion Corporation (NASDAQ: CLN)

Provectus Pharmaceuticals, Inc. (OTC BB: PVCT)

Cell Therapeutics, Inc. (NASDAQ: CTIC)

Protalex, Inc. (OTC BB: PRTX)

Market Basics

Newsletter Publishers

Public Companies